dengu
viru
denv
caus
preval
mosquitoborn
viral
diseas
affect
human
billion
peopl
risk
infect
approxim
million
case
dengu
year
four
denv
serotyp
transmit
human
aed
aegypti
ae
albopictu
mosquito
primarili
urban
periurban
area
tropic
subtrop
countri
worldwid
case
present
classic
dengu
fever
df
debilit
selflimit
ill
manifest
high
fever
retroorbit
pain
sever
myalgiaarthralgia
rash
howev
case
mainli
children
ill
progress
lifethreaten
dengu
hemorrhag
feverdengu
shock
syndrom
dhfdss
character
vascular
leakag
lead
hypovolem
shock
case
fatal
rate
current
licens
vaccin
antivir
therapi
exist
dengu
earli
identif
patient
risk
develop
sever
dengu
critic
provid
time
support
care
reduc
risk
mortal
howev
distinguish
dengu
febril
ill
ofi
earli
ill
challeng
sinc
symptom
nonspecif
common
febril
ill
malaria
leptospirosi
rickettsiosi
typhoid
fever
dengueendem
countri
addit
mani
distinguish
clinic
featur
dhfdss
gener
emerg
day
defervesc
patient
alreadi
critic
ill
although
world
health
organ
recent
establish
new
clinic
guidelin
classifi
dengu
sever
serolog
virolog
molecular
biolog
test
requir
definit
diagnos
denv
infect
mani
endem
countri
laboratori
diagnosi
dengu
often
problemat
due
lack
reagent
expens
delay
obtain
result
patient
suspect
dengu
often
hospit
close
monitor
ensur
proper
treatment
begin
develop
sever
dengu
howev
later
diagnos
ofi
thu
hospit
unnecessarili
great
financi
cost
famili
societi
new
tool
therefor
need
distinguish
dengu
ofi
prevent
death
sever
dengu
mitig
econom
burden
excess
hospit
recent
approach
use
multivari
logist
linear
regress
model
shown
petechia
thrombocytopenia
platelet
count
posit
tourniquet
test
rash
sign
symptom
distinguish
dengu
ofi
howev
result
consist
across
studi
two
studi
consid
clinic
laboratori
featur
accord
day
ill
hospitalbas
studi
result
like
reflect
patient
sever
symptom
clinic
spectrum
symptomat
case
dengueendem
popul
furthermor
none
studi
analyz
data
use
longitudin
statist
method
account
correl
repeat
measur
individu
time
use
longitudin
statist
method
analyz
cohort
data
essenti
util
data
avail
analysi
appropri
estim
withinperson
betweenperson
varianc
measur
time
studi
use
five
year
data
ongo
prospect
cohort
studi
approxim
children
age
year
managua
nicaragua
examin
frequenc
clinic
sign
symptom
day
ill
gener
model
associ
sign
symptom
earli
phase
ill
entir
cours
ill
test
dengueposit
order
account
longitudin
structur
data
odd
ratio
or
confid
interv
calcul
use
gener
estim
equat
gee
adjust
age
gender
august
septemb
communitybas
pediatr
cohort
establish
district
ii
managua
lowtomiddl
incom
area
popul
approxim
studi
activ
base
health
center
flore
viva
hcsfv
public
facil
primari
sourc
health
care
district
ii
resid
briefli
particip
age
year
recruit
housetohous
visit
addit
two
yearold
enrol
year
maintain
age
structur
cohort
children
elig
remain
studi
age
move
studi
area
parentleg
guardian
particip
sign
inform
consent
form
children
year
old
provid
verbal
assent
particip
year
old
given
opportun
continu
addit
year
second
inform
consent
perform
studi
approv
institut
review
board
univers
california
berkeley
nicaraguan
ministri
health
intern
vaccin
institut
seoul
korea
parent
legal
guardian
subject
studi
provid
written
inform
consent
subject
year
age
older
provid
assent
upon
enrol
parentsleg
guardian
particip
encourag
bring
child
ren
hcsfv
first
sign
ill
fever
studi
physician
nurs
train
identif
possibl
dengu
case
provid
medic
care
studi
particip
febril
ill
met
criteria
suspect
dengu
tabl
without
appar
origin
undifferenti
febril
ill
treat
possibl
dengu
case
follow
daili
fever
symptom
persist
visit
studi
medic
personnel
figur
complet
blood
count
cbc
complet
everi
hour
frequent
necessari
indic
physician
case
monitor
close
sever
manifest
transfer
studi
personnel
infecti
diseas
ward
manuel
de
rivera
children
hospit
nation
pediatr
refer
hospit
present
sign
alarm
tabl
addit
annual
healthi
blood
sampl
collect
identifi
denv
infect
previou
year
baselin
cbc
valu
studi
physician
hospit
hcsfv
complet
systemat
data
collect
form
contain
approxim
variabl
tabl
hospit
addit
clinic
data
includ
fluid
balanc
treatment
collect
daili
hospit
ambulatori
followup
visit
team
studi
physician
nurs
data
also
record
medic
test
order
treatment
prescrib
case
consid
laboratoryconfirm
dengu
acut
denv
infect
demonstr
detect
denv
rna
rtpcr
isol
denv
seroconvers
denvspecif
igm
antibodi
observ
macelisa
pair
acut
convalescentphas
sampl
andor
increas
antidenv
antibodi
titer
measur
use
inhibit
elisa
pair
acut
convalesc
sampl
denv
serotyp
identifi
rtpcr
andor
viru
isol
laboratoryconfirm
dengu
case
classifi
sever
dhf
dss
defin
accord
tradit
criteria
tabl
addit
categori
sever
includ
case
present
shock
without
thrombocytopenia
andor
hemoconcentr
dengu
sign
associ
shock
dsa
dengu
fever
compens
shock
dfc
tabl
laboratoryconfirm
case
defin
primari
denv
infect
acutephas
antibodi
titer
measur
inhibit
elisa
convalesc
phase
antibodi
titer
secondari
infect
acut
titer
convalesc
titer
data
first
five
year
studi
august
use
analysi
first
three
day
onset
fever
consid
earli
febril
phase
ill
day
ill
present
determin
date
fever
onset
defin
first
day
ill
report
parentguardian
variabl
definit
describ
tabl
posit
tourniquet
test
examin
use
cutoff
platelet
count
dichotom
use
cutoff
enabl
comparison
day
data
day
ill
includ
analysi
frequenc
dengu
test
result
laboratoryconfirm
dengueposit
versu
dengueneg
diseas
sever
df
versu
sever
dengu
examin
year
demograph
serotyp
immun
respons
frequenc
case
definit
suspect
dengu
examin
dengu
test
result
age
chisquar
test
trend
perform
frequenc
clinic
sign
symptom
day
ill
dengu
sever
also
examin
use
chisquar
test
examin
associ
clinic
sign
symptom
odd
test
dengueposit
versu
dengueneg
odd
ratio
or
confid
interv
ci
calcul
use
gee
model
assum
exchang
correl
structur
robust
standard
error
account
correl
repeat
measur
patient
time
first
or
calcul
use
bivari
model
includ
dengu
test
result
sign
symptom
sign
symptom
examin
multivari
model
adjust
age
gender
data
first
three
day
ill
day
ill
analyz
separ
final
comparison
use
tradit
logist
regress
model
analyz
associ
sign
symptom
test
dengueposit
data
collaps
ill
episod
disregard
repeat
measur
patient
use
model
gener
process
gee
model
analys
conduct
use
stata
statacorp
lp
colleg
station
tx
august
june
episod
febril
ill
evalu
episod
suspect
dengu
undifferenti
fever
figur
possibl
dengu
case
test
neg
laboratoryconfirm
dengueposit
classifi
df
dhf
dss
dsa
dfc
tabl
nearli
sever
dengu
case
df
case
met
case
definit
dengu
proport
laboratoryconfirm
denv
infect
met
case
definit
significantli
increas
age
chisquar
test
trend
p
younger
children
experienc
significantli
undifferenti
febril
ill
due
denv
infect
figur
median
age
case
meet
dengu
case
definit
year
rang
undifferenti
febril
ill
due
denv
infect
year
rang
number
confirm
dengueposit
case
vari
year
expect
tabl
gender
equal
repres
slightli
higher
percentag
femal
experienc
sever
dengu
though
differ
statist
signific
major
df
case
follow
sever
dengu
case
follow
addit
nearli
equal
proport
primari
secondari
immun
respons
among
df
case
wherea
major
sever
dengu
case
secondari
denv
infect
tabl
median
day
ill
present
day
patient
almost
present
day
ill
total
followup
time
children
cohort
personyear
median
followup
year
per
child
shown
figur
sever
sign
symptom
appear
differenti
ofi
df
case
df
case
sever
dengu
case
accord
day
ill
particular
higher
proport
df
sever
dengu
case
experienc
petechia
platelet
leukopenia
posit
tourniquet
test
compar
patient
ofi
higher
proport
sever
case
experienc
petechia
platelet
myalgiaarthralgia
abdomin
pain
compar
df
case
patient
ofi
abdomin
pain
differenti
sever
dengu
case
df
ofi
begin
day
ill
sever
dengu
compar
df
chisquar
p
day
versu
chisquar
p
day
bivari
multivari
analys
perform
use
gee
model
examin
sign
symptom
earli
ill
cours
ill
tabl
day
ill
dengueposit
case
increas
odd
fever
headach
retroorbit
pain
myalgia
arthralgia
vomit
compar
patient
ofi
also
increas
odd
rash
petechia
posit
tourniquet
test
cutoff
leukopenia
platelet
poor
capillari
refil
cold
extrem
hypotens
compar
patient
ofi
contrast
decreas
odd
abdomin
pain
like
featur
appear
later
entir
cours
dengu
ill
day
ill
dengueposit
case
increas
odd
sign
symptom
day
ill
howev
magnitud
point
estim
tend
higher
differ
pronounc
rash
platelet
or
approxim
doubl
magnitud
addit
dengueposit
case
increas
odd
three
addit
sign
symptom
poor
appetit
absenc
cough
increas
hematocrit
gee
analys
data
longitudin
structur
preserv
compar
tradit
logist
regress
analys
data
collaps
febril
episod
point
estim
or
similar
although
confid
interv
logist
regress
model
tend
slightli
narrow
data
shown
studi
describ
clinic
spectrum
pediatr
dengu
start
earli
ill
commun
set
longitudin
statist
analysi
daybyday
clinic
sign
symptom
reveal
signific
associ
test
dengueposit
import
differ
earli
phase
ill
compar
entir
cours
ill
result
stress
import
consid
day
ill
develop
predict
algorithm
realtim
clinic
manag
earli
identif
dengu
case
particularli
risk
sever
dengu
critic
prevent
sever
ill
death
found
laboratoryconfirm
dengu
case
meet
case
definit
suggest
criteria
suffici
identifi
dengu
younger
age
younger
children
may
experi
differ
sign
symptom
adult
may
unabl
commun
symptom
parent
health
care
provid
previou
studi
demonstr
children
may
experi
significantli
cough
vomit
abdomin
pain
rash
epistaxi
oliguria
thrombocytopenia
hepatomegali
shock
compar
adult
although
direct
differ
consist
across
studi
recent
studi
dengu
adult
show
signific
differ
clinic
featur
outcom
across
tenyear
age
group
indic
sign
symptom
associ
denv
infect
may
continu
evolv
past
childhood
differ
confirm
case
definit
may
need
adjust
agespecif
function
effect
younger
children
older
age
group
retroorbit
pain
low
platelet
among
clinic
featur
independ
associ
denv
infect
studi
result
support
studi
dengu
patient
puerto
rico
data
record
time
initi
consult
rather
hospit
studi
thai
children
moreov
result
show
increas
frequenc
abdomin
pain
patient
begin
day
ill
consist
prospect
studi
adult
admit
emerg
depart
martiniqu
posit
tourniquet
test
use
cutoff
also
independ
associ
denv
infect
cutoff
use
studi
indic
cutoff
may
improv
discrimin
denv
infect
howev
classif
scheme
specifi
cutoff
result
support
use
cutoff
cutoff
specifi
clinic
guidelin
major
strength
studi
use
statist
model
design
analysi
longitudin
data
prospect
communitybas
cohort
studi
analyz
earli
clinic
featur
pediatr
dengu
compar
ofi
none
awar
analyz
use
longitudin
statist
method
account
correl
repeat
measur
patient
preserv
longitudin
structur
dataset
use
statist
model
support
repeat
measur
subject
time
account
correl
sign
symptom
experienc
within
individu
differ
day
ill
multipl
episod
longitudin
data
long
collect
dengu
research
rare
analyz
use
appropri
statist
method
may
introduc
bia
find
studi
may
overestim
magnitud
associ
reduc
statist
power
studi
data
lost
collaps
nonlongitudin
analysi
addit
strength
studi
communitybas
enabl
daybyday
captur
inform
earli
cours
ill
full
clinic
spectrum
symptomat
dengu
contrast
nearli
previou
studi
enrol
patient
upon
present
hospit
patient
present
later
thu
studi
unabl
captur
inform
earli
day
ill
mild
diseas
examin
clinic
spectrum
dengu
day
ill
abl
detect
differ
preval
sign
symptom
could
reveal
simpli
analyz
whether
ever
occur
cours
ill
addit
multivari
longitudin
model
abl
identifi
distinguish
featur
dengu
earli
phase
ill
compar
entir
cours
ill
find
import
clinic
practic
sinc
outsid
hospit
set
clinician
may
see
dengu
patient
toward
begin
ill
util
inform
decid
whether
patient
dengu
anoth
febril
ill
result
model
extend
develop
predict
algorithm
aid
clinician
diagnos
suspect
dengu
studi
without
limit
particip
migrat
studi
area
withdrew
studi
howev
retent
rate
approxim
per
year
suggest
bia
loss
followup
would
minim
also
possibl
captur
symptomat
dengu
case
howev
yearli
particip
survey
averag
particip
report
attend
healthcar
provid
outsid
studi
ill
attend
medic
provid
approxim
laboratoryconfirm
dengu
case
captur
cohort
studi
nation
surveil
system
unfortun
due
low
number
sever
dengu
case
studi
suffici
statist
power
compar
sever
dengu
case
df
case
use
gee
model
low
number
may
influenc
lack
signific
associ
sign
sever
dengu
test
dengueposit
studi
use
classif
scheme
diseas
sever
updat
guidelin
classif
dengu
diseas
sever
would
interest
reanalyz
data
futur
studi
use
new
classif
scheme
studi
use
applic
revis
guidelin
recent
perform
summari
studi
one
cohort
studi
provid
earli
data
full
clinic
spectrum
pediatr
dengu
though
found
significantli
increas
odd
associ
sever
clinic
sign
symptom
test
dengueposit
increas
modest
earli
phase
ill
compar
cours
ill
suggest
caution
taken
use
result
entir
cours
ill
develop
predict
algorithm
nonparametr
method
decis
tree
analysi
overcom
limit
tradit
logist
regress
model
recent
appli
develop
algorithm
predict
dengu
diagnosi
diseas
sever
dataadapt
approach
super
learner
less
subject
bia
explor
develop
predict
algorithm
earli
identif
dengu
case
improv
clinic
manag
